Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  lestaurtinib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 1 and under at diagnosis
Sponsor: NCI, Other
Protocol IDs: AALL0631, NCI-2009-00313, COG-AALL0631, CDR0000573996, U10CA098543, U10CA180886, NCT00557193
Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: AAML06P1, CDR0000543398, COG-AAML06P1, NCT00469859
Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: C701a/204/ON/US, NCT00079482
Study of CEP-701 in Treatment of Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: C0701a/203/ON/US, NCT00081601
CEP-701 for PH-negative Myelofibrosis
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007-0070, CS-2007-20040, NCT00494585
N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 30 and under at diagnosis
Sponsor: NCI, Other
Protocol IDs: CDR0000363630, P01CA081403, NANT-2001-03, NCT00084422
Start Over